Guest guest Posted January 12, 2010 Report Share Posted January 12, 2010 FOR IMMEDIATE RELEASE Contact: Corin Ramos, APR 714-970-2268 <corin@...> " XMRV retrovirus and Chronic Fatigue Syndrome, ME (Myalgic Encephalomyelitis), Fibromyalgia and aggressive prostate cancer " WHAT: The Barborka Family Presents a Lecture by S. Bell, M.D: WHEN: Friday, January 15, 2010 - 6:30 pm - 7:30 pm WHERE: LDS Church Building 9801 Newport Blvd, Santa Ana, CA 92705 (North Tustin, 1 mile south of Chapman, near Rocking Horse Ridge entrance) COST: Free ABOUT DR. DAVID S. BELL S. Bell, MD, FAAP, a Harvard graduate, with an MD degree from Boston University School of Medicine in 1971 has come out of retirement to lecture and research XMRV (xenotropic murine leukemia virus-related virus). He completed pediatric specialty and subspecialty training in Behavioral Disorders in Childhood and has been a Harvard Medical School instructor. Dr. Bell operated a family practice in Lyndonville, New York where he studied and diagnosed the outbreak of what was later named chronic fatigue syndrome. The U.S. Dept. of Health and Human Services appointed Dr. Bell to Chair the CFSAC committee from 2003 - 2005. XMRV was first discovered in 2006 in prostate tumors by Silverman, Ph.D. of the Lerner Research Institute at the Cleveland Clinic in 2006. XMRV has also been discovered in patients with CFS/ME, autism and atypical MS by Judy Mikovits, Ph.D and her collaborating scientists. The groundbreaking new discovery of XMRV and X associated neuro-immune disease (XAND) was published in Science Journal on October 8, 2009. http://www.cancer.gov/newscenter/pressreleases/CFSxmrv http://www.cancer.gov/newscenter/pressreleases/XMRV_QandA ----#---- Corin Ramos Walson, APR Walson Communications www.walsonpr.com TEL: 714-970-2268 Cell: 714-865-4147 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.